Clin2
NCT06601465Possibly a fitRecruiting

Vericiguat for cognitive health in heart failure

Heart FailureCognitive Impairment

Treatments studied

Part of Heart & circulation, Mental health clinical trials.

This study tests whether the heart failure medication vericiguat can also improve thinking and memory in people with heart failure who have mild cognitive problems. It involves taking vericiguat pills and having brain scans to track changes.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
120 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are an adult (18 years or older).
  • You have had heart failure for at least 6 months.
  • You have mild-to-moderate memory or thinking problems (such as a MoCA score between 10 and 25).
  • You can take vericiguat (not using long-acting nitrates, riociguat, or PDE-5 inhibitors like sildenafil).
  • You are not pregnant or breastfeeding.
  • You are able to have an MRI scan and do not have an incompatible heart device (like an old ICD or CRT) or certain heart rhythm problems.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06671990Not yet recruiting· Phase 4
Vericiguat for heart failure with CardioMEMS monitoring

This trial tests whether adding vericiguat to your usual heart failure medicines helps reduce pressure in your lungs and improve symptoms. You will have a CardioMEMS sensor already implanted to monitor your heart, and the study will use its readings to guide your care.

NCT07047547Recruiting
Vericiguat study for kidney disease and heart failure patients

This trial tests how a medication called vericiguat works in people with both chronic kidney disease and heart failure. It aims to see if the drug helps manage these conditions together.

Guangzhou, Guangdong
NCT06812546Not yet recruiting· Phase 4
Early vericiguat after heart attack for weakened hearts

This trial tests whether starting the medication vericiguat soon after a heart attack can help people whose hearts are weakened (ejection fraction 45% or lower) and who developed heart failure. Vericiguat is an oral medicine that may reduce strain on the heart and improve outcomes when given early.

Chongqing
NCT05714085Recruiting· Phase 2/Phase 3
Vericiguat study for children with heart failure

This trial tests whether vericiguat helps children with chronic heart failure caused by weaker left heart pumping. It also checks safety and how the medicine behaves in the body (dose and processing).

Los Angeles, California
NCT07829380Recruiting
Heart and brain health study

This study looks at how heart health and brain health are connected. It may help improve thinking and memory in people with mild memory problems.

Singapore
NCT07405944Recruiting· Phase 4
Vericiguat for improving heart function in heart failure

This study tests a medicine called vericiguat (a pill) to see if it can improve the heart's shape and function in people with heart failure and a weakened pump. You would keep taking your usual heart medications plus the study drug.

Izola

Hear when a new Heart failure trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.